The DOI matches its Crossref record; 241 of the 241 references it cites were found in a registry or an index.
Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality
Open accessAbstract
Gene transfer has long been a compelling yet elusive therapeutic modality. First mainly considered for rare inherited disorders, gene therapy may open treatment opportunities for more challenging and complex diseases such as Alzheimer’s or Parkinson’s disease. Today, examples of striking clinical proof of concept, the first gene therapy drugs coming onto the market, and the emergence of powerful new molecular tools have broadened the number of avenues to target neurological disorders but have also highlighted safety concerns and technology gaps. The vector of choice for many nervous system targets currently is the adeno-associated viral (AAV) vector due to its desirable safety profile and strong neuronal tropism. In aggregate, the clinical success, the preclinical potential, and the technological innovation have made therapeutic AAV drug development a reality, particularly for nervous system disorders. Here, we discuss the rationale, opportunities, limitations, and progress in clinical AAV gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–241 of 241
SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice
Dirren, E., Aebischer, J., Rochat, C., Towne, C. L., Schneider, B. L., & Aebischer, P. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.162 · Cited by 67
Belur, L. R., Temme, A., Podetz-Pedersen, K. M., Riedl, M., Vulchanova, L., Robinson, N., Hanson, L. R., Kozarsky, K. F., Orchard, P. J., Frey, W. H., et al. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.187 · Cited by 67
Vandenberghe, L. H., & Wilson, J. M. (2007) · Current Gene Therapy · doi:10.2174/156652307782151416 · Cited by 67
Self-citationBenraiss, A., Toner, M. J., Xu, Q., Bruel‐Jungerman, E., Rogers, E., Wang, F., Economides, A. N., Davidson, B. L., Kageyama, R., Nedergaard, M., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.04.014 · Cited by 66
Yamashita, T., Chai, H., Teramoto, S., Tsuji, S., Shimazaki, K., Muramatsu, S., & Kwak, S. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302935 · Cited by 65
Ma, X., Liu, P., Zhang, X., Jiang, W., Jia, M., Wang, C., Dong, Y., Dang, Y., & Gao, C. (2016) · Scientific Reports · doi:10.1038/srep22404 · Cited by 64
Peden, M. C., Min, J., Meyers, C., Lukowski, Z., Li, Q., Boye, S. L., Levine, M., Hauswirth, W. W., Ratnakaram, R., Dawson, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017140 · Cited by 63
Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain
San Sebastian, W., Samaranch, L., Heller, G., Kells, A. P., Bringas, J., Pivirotto, P., Forsayeth, J., & Bankiewicz, K. S. (2013) · Gene Therapy · doi:10.1038/gt.2013.48 · Cited by 62
Ciron, C., Cressant, A., Roux, F., Raoul, S., Chérel, Y., Hantraye, P., Déglon, N., Schwartz, B., Barkats, M., Heard, J., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2008.155 · Cited by 62
Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease
Hordeaux, J., Dubreil, L., Robveille, C., Deniaud, J., Pascal, Q., Déqueant, B., Pailloux, J., Lagalice, L., Ledevin, M., Babarit, C., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0464-2 · Cited by 62
Mechanisms of Immune Privilege in the Posterior Eye
Stein‐Streilein, J. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2012.740535 · Cited by 61
Wang, D. B., Dayton, R. D., Henning, P. P., Cain, C. D., Zhao, L. R., Schrott, L. M., Orchard, E. A., Knight, D. S., & Klein, R. L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.191 · Cited by 61
Armbruster, N. S., Lattanzi, A., Jeavons, M., van Wittenberghe, L., Gjata, B., Marais, T., Martin, S., Vignaud, A., Voït, T., Mavilio, F., et al. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.60 · Cited by 61
Taschenberger, G., Tereshchenko, J., & Kügler, S. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.03.009 · Cited by 61
MicroRNA-Restricted Transgene Expression in the Retina
Karali, M., Manfredi, A., Puppo, A., Marrocco, E., Gargiulo, A., Allocca, M., Corte, M. D., Rossi, S., Giunti, M., Bacci, M. L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022166 · Cited by 60
Boulis, N. M., Noordmans, A. J., Song, D. K., Imperiale, M. J., Rubin, A. D., Leone, P., During, M. J., & Feldman, E. L. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.025 · Cited by 59
Wolf, D. A., Hanson, L. R., Aronovich, E. L., Nan, Z., Low, W. C., Frey, W. H., & McIvor, R. S. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.02.006 · Cited by 58
Dashkoff, J., Lerner, P., Truong, N., Klickstein, J. A., Fan, Z., Mu, D., Maguire, C. A., Hyman, B. T., & Hudry, E. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.81 · Cited by 58
Self-citationRockwell, H. E., McCurdy, V. J., Eaton, S. C., Wilson, D. U., Johnson, A. K., Randle, A. N., Bradbury, A. M., Gray‐Edwards, H. L., Baker, H. J., Hudson, J. A., et al. (2015) · ASN NEURO · doi:10.1177/1759091415569908 · Cited by 56
A QUANTITATIVE STUDY OF CELL PROLIFERATION IN EPENDYMA AND CHOROID PLEXUS IN THE POSTNATAL RAT BRAIN
CHAUHAN, A. N., & Lewis, P. D. (1979) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1979.tb00629.x · Cited by 55
Löw, K., Aebischer, P., & Schneider, B. L. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.174 · Cited by 54
Li, Z., Malani, N., Li, M., Brady, T., Xie, J., Bell, P. L., Li, S., Jones, H., Wilson, J. M., Flotte, T. R., et al. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.112 · Cited by 52
Karumuthil‐Melethil, S., Marshall, M. S., Heindel, C., Jakubauskas, B., Bongarzone, E. R., & Gray, S. J. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23882 · Cited by 51
Gene Therapeutic Reversal of Peripheral Olfactory Impairment in Bardet-Biedl Syndrome
Williams, C. L., Uytingco, C. R., Green, W. W., McIntyre, J. C., Ukhanov, K., Zimmerman, A. D., Shively, D. T., Zhang, L., Nishimura, D. Y., Sheffield, V. C., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.02.006 · Cited by 50
Effects of AAV-2-mediated aspartoacylase gene transfer in the tremor rat model of Canavan disease
McPhee, S., Francis, J. S., Janson, C. G., Serikawa, T., Hyland, Κ., Ong, E., Raghavan, S., Freese, A. B., & Leone, P. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.12.007 · Cited by 48
Rhodopsin targeted transcriptional silencing by DNA-binding
Botta, S., Marrocco, E., de Prisco, N., Curion, F., Renda, M., Sofia, M., Lupo, M., Carissimo, A., Bacci, M. L., Gesualdo, C., et al. (2016) · eLife · doi:10.7554/elife.12242 · Cited by 48
Hinderer, C. J., Katz, N., Louboutin, J., Bell, P. L., Yu, H., Nayal, M., Kozarsky, K., O'Brien, W. T., Goode, T. L., & Wilson, J. M. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.101 · Cited by 48
Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model
Georgiou, E., Sidiropoulou, K., Richter, J., Papaneophytou, C. P., Sargiannidou, I., Kagiava, A., von Jonquières, G., Christodoulou, C., Klugmann, M., & Kleopa, K. A. (2016) · Brain · doi:10.1093/brain/aww351 · Cited by 48
Wang, L., Xiao, R., Andrés‐Mateos, E., & Vandenberghe, L. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182473 · Cited by 44
Self-citationAAV Infection: Protection from Cancer
Srivastava, A., & Carter, B. J. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.147 · Cited by 34
AAV-Mediated Astrocyte-Specific Gene Expression under Human ALDH1L1 Promoter in Mouse Thalamus
Koh, W., Park, Y. M., Lee, S. E., & Lee, C. J. (2017) · Experimental Neurobiology · doi:10.5607/en.2017.26.6.350 · Cited by 34
Hironaka, K., Yamazaki, Y., Hirai, Y., Yamamoto, M., Miyake, N., Miyake, K., Okada, T., Morita, A., & Shimada, T. (2015) · Scientific Reports · doi:10.1038/srep13104 · Cited by 32
Li, D., Liu, C., Yang, C., Wang, D., Wu, D., Qi, Y., Su, Q., Gao, G., Xu, Z., & Guo, Y. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.10.001 · Cited by 26
Appu, A. P., Moffett, J. R., Arun, P., Moran, S., Nambiar, V., Krishnan, J. K. S., Puthillathu, N., & Namboodiri, A. M. A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00161 · Cited by 25
Adeno-associated virus type 2 as an oncogenic virus in human hepatocellular carcinoma
Nault, J., Datta, S., Imbeaud, S., Franconi, A., & Zucman‐Rossi, J. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1095271 · Cited by 15
Progress in gene and cell therapies for the neuronal ceroid lipofuscinoses
Donsante, A., & Boulis, N. M. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1492544 · Cited by 15
Jergová, S., Gordon, C. E., Gajavelli, S., & Sagen, J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00406 · Cited by 14
Hwu, W., Lee, N., Chien, Y., Muramatsu, S., & Ichinose, H. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-411512-5.00013-0 · Cited by 11
Keeler, C. E. (1947) · PubMed · Cited by 10
Kennedy, L. H., & Rinholm, J. E. (2017) · Journal of Visualized Experiments · doi:10.3791/56237 · Cited by 9
Breaking and Sealing Barriers in Retinal Gene Therapy
Miller, J. W., & Vandenberghe, L. H. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.08.003 · Cited by 9
Self-citation
Cited by
Mitochondrial Diseases: Hope for the Future
Russell, O. M., Gorman, G. S., Lightowlers, R. N., & Turnbull, D. M. (2020) · Cell · doi:10.1016/j.cell.2020.02.051 · Cited by 459
Viral vector‐based gene therapies in the clinic
Zhao, Z., Anselmo, A. C., & Mitragotri, S. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10258 · Cited by 269
GBA Variants and Parkinson Disease: Mechanisms and Treatments
Smith, L., & Schapira, A. H. V. (2022) · Cells · doi:10.3390/cells11081261 · Cited by 256
Adeno-Associated Virus Toolkit to Target Diverse Brain Cells
Challis, R. C., Ravindra Kumar, S., Chen, X., Goertsen, D., Coughlin, G. M., Hori, A. M., Chuapoco, M. R., Otis, T. S., Miles, T. F., & Gradinaru, V. (2022) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-111020-100834 · Cited by 148
AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges
Kang, L., Jin, S., Wang, J., Lv, Z., Xin, C., Tan, C., Zhao, M., Wang, L., & Liu, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.067 · Cited by 131
Metadata
- Authors
- Hudry, E., & Vandenberghe, L. H.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 101
- Issue
- 5
- Pages
- 839-862
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2921986557
- Cited by
- 369
- References
- 241
- FWCI
- 26.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.